Pharma & Biotech Valuation
The purpose of this study is to provide corporate finance professionals, managers, and investors, an overview of valuation fundamentals...
Venture Capital – Trends & Analysis
The purpose of the study is to provide corporate finance professionals, operators, and investors, an overview of the fundamental trends...
Specialty Pharmacy Report 2017
In this 2017 Specialty Pharmacy Report, we highlight today’s growth areas and opportunities, with an aim to provide insight into current...
Opportunity Themes
Dominant longer-term investment themes for healthcare investors will be true innovation or cost-control. Successful business models...
A Challenged Environment
The passage of the Patient Protection and Affordable Care Act (PPACA) in March 2010 and continued cost pressures may drive a radical...
2016 1H Snapshot: Healthcare & Life Sciences
US health services deal volume in Q2 2016 increased by approximately 8% from Q1 2016and 16% on a year-over-year basis. 239 health...
Orphan Drug Development
The growth of pharma industries has slowed in recent years because of various reasons such as patent expiries, generic competition,...
The Future of Healthcare in China
China is currently undergoing unprecedented political, demographic, and economic change. With a government stated goal of providing...
U.S. Healthcare Outlook
In corporate development there are few investable and actionable certainties. Here today, we face one of the most significant certainties...
Specialty Pharmacy Report 2015
In this 2015 Specialty Pharmacy Report, we highlight today’s growth areas and opportunities,with an aim to provide insight into current...
